- 全部删除
- 您的购物车当前为空
JNJ-1013是一种选择性的IRAK1 PROTAC降解剂,对IRAK1的IC50=72 nM,而对IRAK4和VHLFP的IC50分别为443和1071nM,能够抗增殖和诱导凋亡,增加cleavaged-PARP表达,降低IRAK1、p-IKBα、pSTAT3(Tyr705)的水平。
JNJ-1013是一种选择性的IRAK1 PROTAC降解剂,对IRAK1的IC50=72 nM,而对IRAK4和VHLFP的IC50分别为443和1071nM,能够抗增殖和诱导凋亡,增加cleavaged-PARP表达,降低IRAK1、p-IKBα、pSTAT3(Tyr705)的水平。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 865 | In stock |
JNJ-1013 相关产品
产品描述 | JNJ-1013 is a selective IRAK1 PROTAC degrader with an IC50 of 72 nM for IRAK1, compared to IC50s of 443 and 1071 nM for IRAK4 and VHLFP respectively. It exerts antiproliferative and proapoptotic effects, increases cleaved-PARP expression, and reduces levels of IRAK1, p-IKBα, and pSTAT3(Tyr705). |
靶点活性 | IRAK1:72 nM, VHL FP:1071 nM, IRAK4:443 nM |
体外活性 | 方法:JNJ-1013 (1.5-10000 nM,24 小时) 处理HEK293T细胞,WesternBlot检测目标蛋白的水平的变化。 |
别名 | JNJ1013 |
分子量 | 878.05 |
分子式 | C46H55N9O7S |
CAS No. | 2597343-08-1 |
存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
溶解度信息 | DMSO: 20 mg/mL (22.78 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
DMSO
|
评论内容